Company Overview of iPierian, Inc.
iPierian, Inc., a biopharmaceutical company, engages in the industrialization of induced pluripotent stem cell technology; and discovery and development of therapeutics using cells as models of human disease. It focuses on neurological diseases, including spinal muscular atrophy, amyotrophic lateral sclerosis, and Alzheimer’s disease. The company was formerly known as iZumi Bio, Inc. and changed its name in July 2009. iPierian, Inc. was founded in 2007 and is based in South San Francisco, California.
951 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2007
Key Executives for iPierian, Inc.
iPierian, Inc. Key Developments
Similar Private Companies By Industry
|TEI Biosciences Inc.||United States|
|Entropin Inc.||United States|
|RxGen, Inc.||United States|
|Matrivax Research & Development Corp.||United States|
|Percival Scientific Incorporated||United States|
Recent Private Companies Transactions
September 4, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Frederick, MD | Computer Sciences Corporation (CSC)Posted: Nov 26
- Billerica, MA | Mergis Group, A Division of SpherionPosted: Dec 10
- Summit, NJ | DiversantPosted: Jul 03
- South San Francisco, CA | GenentechPosted: Dec 11
Sponsored Financial Commentaries
To contact iPierian, Inc., please visit www.ipierian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.